CA2621025C - An ultra-high yield intravenous immune globulin preparation - Google Patents

An ultra-high yield intravenous immune globulin preparation Download PDF

Info

Publication number
CA2621025C
CA2621025C CA2621025A CA2621025A CA2621025C CA 2621025 C CA2621025 C CA 2621025C CA 2621025 A CA2621025 A CA 2621025A CA 2621025 A CA2621025 A CA 2621025A CA 2621025 C CA2621025 C CA 2621025C
Authority
CA
Canada
Prior art keywords
salt
euglobulin
depleted intermediate
depleted
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2621025A
Other languages
English (en)
French (fr)
Other versions
CA2621025A1 (en
Inventor
Gene Zurlo
Dennis Curtin
Allan Louderback
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Plasma Technologies LLC
Original Assignee
Plasma Technologies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plasma Technologies LLC filed Critical Plasma Technologies LLC
Priority claimed from PCT/US2006/030465 external-priority patent/WO2007030244A2/en
Publication of CA2621025A1 publication Critical patent/CA2621025A1/en
Application granted granted Critical
Publication of CA2621025C publication Critical patent/CA2621025C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2621025A 2005-09-01 2006-08-04 An ultra-high yield intravenous immune globulin preparation Active CA2621025C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US11/217,956 US20070049732A1 (en) 2005-09-01 2005-09-01 Ultra-high yield intravenous immune globulin preparation
US11/217,956 2005-09-01
US11/232,527 2005-09-22
US11/232,527 US7879331B2 (en) 2005-09-01 2005-09-22 Ultra-high yield intravenous immune globulin preparation
PCT/US2006/030465 WO2007030244A2 (en) 2005-09-01 2006-08-04 An ultra-high yield intravenous immune globulin preparation

Publications (2)

Publication Number Publication Date
CA2621025A1 CA2621025A1 (en) 2007-03-15
CA2621025C true CA2621025C (en) 2014-10-14

Family

ID=37805216

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2621025A Active CA2621025C (en) 2005-09-01 2006-08-04 An ultra-high yield intravenous immune globulin preparation

Country Status (6)

Country Link
US (3) US20070049732A1 (de)
JP (1) JP5178518B2 (de)
CN (1) CN101528776B (de)
AT (1) ATE541858T1 (de)
CA (1) CA2621025C (de)
ES (1) ES2384930T3 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG162788A1 (en) 2005-06-14 2010-07-29 Amgen Inc Self-buffering protein formulations
AU2009236305B2 (en) * 2008-04-15 2014-04-10 Grifols Therapeutics Inc. Two-stage ultrafiltration/diafiltration
WO2010148117A1 (en) 2009-06-17 2010-12-23 Scantibodies Laboratory, Inc. Therapeutic and diagnostic affinity purified specific polyclonal antibodies
IT1397061B1 (it) 2009-12-28 2012-12-28 Kedrion Spa Nuovo processo di purificazione su scala industriale di gammaglobuline da plasma umano per uso industriale.
PL2734544T3 (pl) 2011-07-18 2021-05-31 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Sposoby i kompozycje do hamowania patologii związanej z poliomawirusem
US9696305B2 (en) 2011-10-31 2017-07-04 Bloodworks Antibody response phenotyping
CN102949719A (zh) * 2012-04-28 2013-03-06 上海市徐汇区中心医院 静脉注射免疫球蛋白抑制霍乱毒素和半乳糖凝集素-1结合到神经节苷脂gm1
US9663553B2 (en) 2014-01-29 2017-05-30 Hemarus Therapeutics Limited Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma
US9556253B2 (en) 2014-12-02 2017-01-31 Hemarus Therapeutics Limited Process for increased yield of immunoglobulin from human plasma
WO2017066683A1 (en) * 2015-10-15 2017-04-20 Plasma Technologies, Llc Methods for extracting proteins from blood plasma
CA3012694A1 (en) 2016-02-03 2017-08-10 Plasma Technologies, Llc Methods for extracting proteins from a blood-based material
MX2019004580A (es) 2016-10-21 2019-08-12 Amgen Inc Formulaciones farmaceuticas y metodos para prepararlas.
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
CN108008060B (zh) * 2017-09-21 2020-07-28 中国农业科学院农业质量标准与检测技术研究所 一种饲料中羟脯氨酸的测定方法及试剂
US10815270B1 (en) * 2019-09-20 2020-10-27 Plasma Technologies, Llc Compositions and methods for high efficiency protein precipitation
US10836790B1 (en) * 2019-09-20 2020-11-17 Plasma Technologies, Llc Therapeutic protein compositions and methods
CA3203540A1 (en) * 2020-12-28 2022-07-07 Eugene ZURLO Systems and methods for process scale isolation of immunoglobulin g
CN115369104B (zh) * 2022-09-27 2023-09-08 四川新川义生物科技有限责任公司 一种精制胃蛋白酶的方法

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2390074A (en) * 1942-02-09 1945-12-04 Research Corp Protein product and process
US4067863A (en) 1969-03-28 1978-01-10 Watt John G Blood plasma fractionation
CA1064396A (en) 1975-02-18 1979-10-16 Myer L. Coval Fractional precipitation of gamma globulin with polyethylene glycol
JPS5234918A (en) 1975-09-06 1977-03-17 Biotest Serum Institut Gmbh Production of gmmaglobulin suitable for dosing into vein
US4126605A (en) 1975-12-29 1978-11-21 Plasmesco Ag Process of improving the compatibility of gamma globulins
US4165370A (en) * 1976-05-21 1979-08-21 Coval M L Injectable gamma globulin
US4136094A (en) 1977-08-31 1979-01-23 The Regents Of The University Of Minnesota Preparation of intravenous human and animal gamma globulins and isolation of albumin
US4296027A (en) 1977-08-31 1981-10-20 The Regents Of The University Of Minnesota Pure intravenous human and animal gamma globulins
GB2040990B (en) * 1977-11-17 1982-10-06 Procter & Gamble Granular detergent compositions for improved greasy soil removal
US4163370A (en) 1977-11-21 1979-08-07 Corning Glass Works Controlling the drawing rollers to produce diameter perturbations in an optical waveguide
DE2835843A1 (de) 1978-08-16 1980-02-28 Blutspendedienst Dt Rote Kreuz Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten gammaglobulinloesung
DE2837168A1 (de) 1978-08-25 1980-03-06 Blutspendedienst Dt Rote Kreuz Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten immunglobulinloesung
DE2901822A1 (de) 1979-01-18 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung einer fuer die intravenoese applikation geeigneten immunglobulinloesung, die igm in ankonzentrierter form enthaelt
US4246085A (en) 1979-02-16 1981-01-20 United Kingdom Atomic Energy Authority Fractionation of proteins
JPS5681521A (en) 1979-12-10 1981-07-03 Toyo Soda Mfg Co Ltd Separation of blood serum and protein
US4321192A (en) 1980-01-10 1982-03-23 Ionics Incorporated Fractionation of protein mixtures by salt addition followed by dialysis treatment
JPS5855432A (ja) 1981-09-29 1983-04-01 Fujirebio Inc 静脈注射用免疫グロブリンの製法
US4371520A (en) 1981-10-28 1983-02-01 The Green Cross Corporation Process for preparing immunoglobulin suitable for intravenous injection
US4624780A (en) 1982-06-28 1986-11-25 Alpha Therapeutic Corporation Fractionation of blood plasma
US4639513A (en) 1984-02-02 1987-01-27 Cuno Inc. Intravenously injectable immunoglobulin G (IGG) and method for producing same
US4486282A (en) * 1983-02-22 1984-12-04 University Patents, Inc. Precipitation of proteins from salt-containing proteinaceous fluids employing a desalting treatment, and use thereof in selective plasmapheresis
JPS59157017A (ja) 1983-02-25 1984-09-06 Green Cross Corp:The 静脈投与用γ−グロブリン製剤
FR2543448A1 (fr) 1983-04-01 1984-10-05 Rhone Poulenc Spec Chim Procede de fractionnement du plasma
US4835257A (en) 1984-07-07 1989-05-30 Armour Pharma Gmbh Process for preparing gamma globulin suitable for intravenous administration using peg and a citrate buffer
DE3640513A1 (de) 1986-11-27 1988-06-09 Biotest Pharma Gmbh Verfahren zur herstellung eines virussicheren, lagerstabilen und intravenoes vertraeglichen immunglobulin-g-praeparates
US5177194A (en) * 1990-02-01 1993-01-05 Baxter International, Inc. Process for purifying immune serum globulins
US5310877A (en) 1993-04-08 1994-05-10 E. I. Du Pont De Nemours And Company Method for separating serum albumin and gamma globulin
US5429746A (en) * 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
US5561115A (en) 1994-08-10 1996-10-01 Bayer Corporation Low temperature albumin fractionation using sodium caprylate as a partitioning agent
TW491855B (en) 1996-08-07 2002-06-21 Csl Ltd Purification of immunoglobulins
GB9705810D0 (en) 1997-03-20 1997-05-07 Common Services Agency Intravenous immune globulin
AT407159B (de) * 1997-06-13 2001-01-25 Immuno Ag Verfahren zur abreicherung von viralen und molekularen pathogenen aus einem biologischen material
US5886154A (en) 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies
ES2527915T3 (es) 1998-06-09 2015-02-02 Csl Behring Ag Producto de inmunoglobulina G (IgG) líquido
AUPP971399A0 (en) * 1999-04-12 1999-05-06 Life Therapeutics Limited Separation of plasma components
SE0001128D0 (sv) 2000-03-30 2000-03-30 Amersham Pharm Biotech Ab A method of producing IgG
US7297716B2 (en) * 2000-10-23 2007-11-20 Shanbrom Technologies, Llc Enhanced production of blood components, blood cells and plasma without freezing
US6881731B1 (en) * 2000-10-23 2005-04-19 Shanbrom Technologies, Llc Enhancers for microbiological disinfection
ES2184594B1 (es) * 2001-01-17 2004-01-01 Probitas Pharma Sa Procedimiento para la produccion de gammaglobulina g humana inactivada de virus.
MXPA03007069A (es) * 2001-02-07 2004-10-15 Shanbrom Tech Llc Acido carboxilico tal como acido citrico para desinfectar o mejorar la produccion de productos sanguineos tales como el plasma, crioprecipitado y/o plaqueta.
US6806355B2 (en) 2001-08-14 2004-10-19 Statens Serum Institut Purification process for large scale production of Gc-globulin, the Gc-globulin produced hereby, a use of Gc.globulin and a Gc-globulin medicinal product
US6893639B2 (en) * 2001-10-19 2005-05-17 Hemacare Corporation Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates
US6881573B2 (en) 2003-09-12 2005-04-19 Allan L. Louderback Augmented solvent/detergent method for inactivating enveloped and non-enveloped viruses

Also Published As

Publication number Publication date
US20070049732A1 (en) 2007-03-01
US20080242844A1 (en) 2008-10-02
JP2009507015A (ja) 2009-02-19
US20070049733A1 (en) 2007-03-01
ATE541858T1 (de) 2012-02-15
CN101528776B (zh) 2014-01-08
CN101528776A (zh) 2009-09-09
US7879331B2 (en) 2011-02-01
CA2621025A1 (en) 2007-03-15
JP5178518B2 (ja) 2013-04-10
ES2384930T3 (es) 2012-07-16

Similar Documents

Publication Publication Date Title
CA2621025C (en) An ultra-high yield intravenous immune globulin preparation
WO2007030244A3 (en) An ultra-high yield intravenous immune globulin preparation
JP2009507015A5 (de)
TWI596107B (zh) 單株抗體之新穎純化方法
CN105018416A (zh) 一种悬浮培养bhk-21细胞的无血清无动物源培养基及其配制方法
CN105431454A (zh) 用于生产单克隆抗体的改进方法
CA2569465A1 (en) Method for purifying erythropoietin
CN109761833A (zh) 一种l-亮氨酸的分离纯化方法
DE69118056T2 (de) Anticoagulatorische Zusammensetzung aus LACI und sulfatierten Polysacchariden
WO2007078848A3 (en) Preparation of pharmaceutical salts of 3-o-(3',3'-dimethlsuccinyl) betulinic acid
JPS6222970B2 (de)
US5595901A (en) Method for obtaining protective active and inactive adenylate cyclase from Bordetella parapertussis
JP4355574B2 (ja) 点眼剤
CA1328070C (fr) Procede de purification d'antigenes proteiques de bacteries appartenant au genre bordetella, en vue de l'obtention d'un vaccin acellulaire
WO2023235660A3 (en) Flavivirus immunogens and vaccine compositions and methods of using the same
BRPI0306851A2 (pt) aplicação de derivados de polissacarídeos como substâncias antiinfectantes
CA1279593C (en) Cholesterol-rich fraction, process therefor and use thereof in cell culture
JPS61277623A (ja) 哺乳動物の血漿または血清あるいはその分画からコレステロールに富んだ分画を単離しかつ精製する方法
JPH1180206A (ja) ヒメマツタケ培養物から分離されるグルコマンナン及びこれを有効成分とする抗腫瘍剤
JPH075472B2 (ja) 皮膚外用剤
CN103205478B (zh) 一种重组人促红素的工业化生产方法
JP2753938B2 (ja) 液性免疫増強用医薬組成物
KR20160120637A (ko) 능이버섯에서 추출된 추출물, 그 제조 방법 및 그 용도
JP2001029039A (ja) ローヤルゼリー中の有効成分の精製法
HUP0004005A2 (hu) Eljárás (+)-transz-krizantém-monokarbonsav előállítására

Legal Events

Date Code Title Description
EEER Examination request